Intelicare Holdings logo
ICR
Health Care Equipment & Services

Intelicare Holdings

Short interest
0.00%
0.00 pp 30d
as of 22 Sept 2025
Reported shorts
2.5K
Shares on issue
486.188M

Intelicare Holdings (ICR) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$2.7M (source: ASX (Markit))vs $956.7K (FY25)
ASX (Markit), as at 14 Oct 2026
NPAT
−$2.1M (source: ASX (Markit))vs −$2.2M (FY25)
ASX (Markit), as at 14 Oct 2026
EPS (diluted)
−$0.004 (source: Derived: trailing 12 months at year end)vs −$0.005 (FY25)
Derived: trailing 12 months at year end, as at 14 Oct 2026
Rev YoY
+178.2%FY
EPS YoY
n/aTTM
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of Annual Report to shareholders, 13 Oct 2026

InteliCare Holdings reported a statutory net loss of $2,097,816 for FY2026, an improvement from the $2,244,263 loss in FY2025. No dividend was declared. The company highlighted significant commercial progress, including a five-year $8.8 million agreement with mecwacare and expansion with Hardi Aged Care, positioning for scaled growth in FY2027.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
76.7%
Operating margin
−96.4%
Net margin
−78.8%
FCF margin
−44.6%
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
−18.1×
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
n/a
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

ICR income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$2.7M (source: ASX (Markit))$956.7K$280.3K$404.3K
Gross profit$2.0M (source: Derived: trailing 12 months at year end)$956.7K$280.3K$404.3K
Operating income−$2.6M (source: Derived: trailing 12 months at year end)−$2.8M−$3.1M−$4.1M
EBITDA−$1.9M (source: Derived: trailing 12 months at year end)−$2.1M−$2.1M−$2.9M
EBIT−$2.0M (source: Derived: trailing 12 months at year end)−$2.2M−$2.2M−$3.0M
Interest expense$141.8K (source: Derived: trailing 12 months at year end)$70.1K$83.9K$22.9K
Pretax income−$2.1M (source: Derived: trailing 12 months at year end)−$2.2M−$2.3M−$3.0M
Tax$0 (source: Derived: trailing 12 months at year end)$0$0$0
NPAT−$2.1M (source: ASX (Markit))−$2.2M−$2.3M−$3.0M
Net interest income−$142.6K (source: Derived: trailing 12 months at year end)−$76.4K−$81.8K−$17.4K
EPS basic−$0.004 (source: Derived: trailing 12 months at year end)−$0.005−$0.010−$0.018
EPS diluted−$0.004 (source: Derived: trailing 12 months at year end)−$0.005−$0.010−$0.018
Sharesn/a487.3M292.1M210.1M
  • ASX (Markit)
  • Derived: trailing 12 months at year end